Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Depreciation & Amortization (CF): 2020-2022

Historic Depreciation & Amortization (CF) for Atea Pharmaceuticals (AVIR) over the last 3 years, with Dec 2022 value amounting to $104,000.

  • Atea Pharmaceuticals' Depreciation & Amortization (CF) rose 1385.71% to $104,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $260,000, marking a year-over-year increase of 796.55%. This contributed to the annual value of $416,000 for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2022, Atea Pharmaceuticals' Depreciation & Amortization (CF) is $104,000, which was down 1.89% from $106,000 recorded in Q3 2022.
  • In the past 5 years, Atea Pharmaceuticals' Depreciation & Amortization (CF) registered a high of $106,000 during Q3 2022, and its lowest value of $4,000 during Q1 2020.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $7,000 (2022), whereas its average is $25,667.
  • Data for Atea Pharmaceuticals' Depreciation & Amortization (CF) shows a peak YoY soared of 1,414.29% (in 2022) over the last 5 years.
  • Quarterly analysis of 3 years shows Atea Pharmaceuticals' Depreciation & Amortization (CF) stood at $6,000 in 2020, then grew by 16.67% to $7,000 in 2021, then surged by 1,385.71% to $104,000 in 2022.
  • Its last three reported values are $104,000 in Q4 2022, $106,000 for Q3 2022, and $43,000 during Q2 2022.